The short version
5 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $136.69 per unit over the past year.
Market view
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
10 marketed package NDCs · 5 active manufacturers
Most dispensed: 30 mg; 120 mg; TENOFOVIR ALAFENAMIDE FUMARATE 15 mg · Tablet · #30 tablets/bottle, plastic · 50 mg; 200 mg; TENOFOVIR ALAFENAMIDE FUMARATE 25 mg · Tablet · #30 tablets/blister pack · 50 mg; 200 mg; TENOFOVIR ALAFENAMIDE FUMARATE 25 mg · Tablet · #30 tablets/bottle, plastic
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $136.69 · middle half $136.64–$136.73 · full range $136.64–$136.73 · 4 products · 5 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- BiktarvyAug 19, 2026Price upNADAC $136.64075 → $136.64291 per unit (0%)
- BiktarvyAug 19, 2026Price upNADAC $136.64075 → $136.64291 per unit (0%)
- BiktarvyAug 19, 2026Price downNADAC $136.74616 → $136.73311 per unit (-0.01%)
- BiktarvyAug 19, 2026Price downNADAC $136.74616 → $136.73311 per unit (-0.01%)
- BiktarvyJul 22, 2026Price upNADAC $136.74014 → $136.74616 per unit (0%)
- BiktarvyJul 22, 2026Price upNADAC $136.74014 → $136.74616 per unit (0%)
- BiktarvyJul 22, 2026Price downNADAC $136.66953 → $136.64075 per unit (-0.02%)
- BiktarvyJul 22, 2026Price downNADAC $136.66953 → $136.64075 per unit (-0.02%)
Same drug class
Other molecules FDA puts in Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- abacavir sulfate, dolutegravir sodium, lamivudine· 1 maker
- dolutegravir sodium and lamivudine· 1 maker
- elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide· 1 maker
- emtricitabine and tenofovir alafenamide· 1 maker
- emtricitabine, rilpivirine and tenofovir disoproxil fumarate· 1 maker
- emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide· 1 maker
- emtricitabine, rilpivirine, tenofovir disoproxil fumarate· 1 maker
- emtricitabine/tdf· 1 maker
- entecavir anhydrous· 1 maker
- lamivudine and tenofovir disoproxil fumarate· 1 maker
- tenofovir alafenamide· 1 maker
- tenofovir disoproxil fumarate tablets· 1 maker
Common questions
- Is Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate in shortage right now?
- No. FDA does not currently list Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate?
- 5 companies have marketed Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate cost?
- The typical pharmacy pays about $136.69 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.